Notice of NHGRI’s Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"

Notice Number: NOT-HG-20-034

Key Dates
Release Date: March 31, 2020

Related Announcements
None

Issued by
National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to inform applicants that the National Human Genome Research Institute (NHGRI) will participate, effective immediately, in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)".

The following changes and updates are made to PA-18-935 (shown in italics) to reflect NHGRI’s participation in this FOA.


Part 1. Overview Information


Components of Participating Organizations

National Institute on Aging (NIA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Institute of Environmental Health Sciences (NIEHS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Human Genome Research Institute (NHGRI)


Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.866, 93.855, 93.279, 93.847, 93.242, 93.113, 93.272, 93.286,93.172


All other aspects of this Notice remain the same.

Inquiries

Please direct all inquiries to:

Jennifer Troyer, Ph.D.
NIH National Human Genome Research InstituteTelephone: 301-312-3276
Email: jennifer.troyer@nih.gov